These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 5551426
1. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease]. Postma JU, Stam FC, Meerlo HJ. Ned Tijdschr Geneeskd; 1971 Apr 17; 115(16):701-7. PubMed ID: 5551426 [No Abstract] [Full Text] [Related]
2. [Treatment of Parkinson's syndrome using L-dopa. 2]. Glabb J, Hübner W, Glabb S. Z Arztl Fortbild (Jena); 1973 Aug 01; 67(15):745-53. PubMed ID: 4594383 [No Abstract] [Full Text] [Related]
3. Parkinson's disease: L-dopa treatment and handwriting area. Knopp W, Paulson G, Allen JN, Smeltzer D, Brown FD, Kose W. Curr Ther Res Clin Exp; 1970 Mar 01; 12(3):115-25. PubMed ID: 4985489 [No Abstract] [Full Text] [Related]
4. [Our experience with the treatment of Parkinson's disease with L-dopa]. Buscaino GA, Campanella G. Acta Neurol (Napoli); 1971 Mar 01; 26(1):46-60. PubMed ID: 5553941 [No Abstract] [Full Text] [Related]
5. [L-dopa effect in Parkinson's syndrome]. Römer F, Bettag W, Bock WJ. Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715 [No Abstract] [Full Text] [Related]
6. [Treatment of Parkinson's syndrome with L-dopa]. Ljung O. Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135 [No Abstract] [Full Text] [Related]
7. [Parkinson's disese. Treatment with L-dopa]. Herskovits E, Matera R. Prensa Med Argent; 1969 Oct 31; 56(35):1674-80. PubMed ID: 5399419 [No Abstract] [Full Text] [Related]
8. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa]. Paci A, Freddi A, Barba C. Riv Neurol; 1973 Oct 31; 43(1):15-39. PubMed ID: 4698011 [No Abstract] [Full Text] [Related]
9. [Personal experience in the treatment of Parkinson's disease with L-Dopa]. Figuerido JA, De la Herrán J. Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794 [No Abstract] [Full Text] [Related]
10. [Silent period in patients with Parkinson's disease treated with L-Dopa]. Palao Sánchez A. Arch Neurobiol (Madr); 1973 Dec 31; 36(1):47-56. PubMed ID: 4706780 [No Abstract] [Full Text] [Related]
11. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride]. Scotti G. Sist Nerv; 1970 Dec 31; 22(2):144-52. PubMed ID: 5504553 [No Abstract] [Full Text] [Related]
12. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome]. Lombardo L. Arch Invest Med (Mex); 1973 Dec 31; 4(3):215-24. PubMed ID: 4784173 [No Abstract] [Full Text] [Related]
13. Dopa in Parkinson's disease. Rosenberg H. N Engl J Med; 1969 Mar 27; 280(13):730. PubMed ID: 5766091 [No Abstract] [Full Text] [Related]
14. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease. Hare TA, Vanna S, Beasley B, Chambers R, Vogel WH. J Lab Clin Med; 1971 Feb 27; 77(2):319-25. PubMed ID: 5540775 [No Abstract] [Full Text] [Related]
19. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method]. Hirayama K, Uono M, Nakanishi T, Kato N, Nagao Y. Shinkei Kenkyu No Shimpo; 1971 Feb 27; 15(1):267-85. PubMed ID: 4937721 [No Abstract] [Full Text] [Related]
20. [L-Dopa in the treatment of Parkinson's disease]. Warot P. Lille Med; 1971 Feb 27; 17():Suppl:329-34. PubMed ID: 5153001 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]